D4.1 Results of the gap analysis
Regulation of advanced therapy medicinal products in the EU | RAPS
Drugs and Devices: Comparison of European and U.S. Approval Processes - ScienceDirect
EUR-Lex - 52020DC0442 - EN - EUR-Lex
What can be done? Digital Media Policy Options for Europe (and beyond) | Reuters Institute for the Study of Journalism
B2 – Analytical report on EU law applicable to sharing of non-personal data Support Centre for data sharing
Improving the Safety of Medicines in the European Union: From Signals to Action - Potts - 2020 - Clinical Pharmacology & Therapeutics - Wiley Online Library
EUR-Lex - 52018SC0041 - LV - EUR-Lex
Administrative Sciences | Free Full-Text | New Regulations on Medical Devices in Europe: Are They an Opportunity for Growth? | HTML
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches | npj Digital Medicine
ENCePP Guide on Methodological Standards in Pharmacoepidemiology (Revision 5)
PDF) Input analysis for two public consultations on the EU Clinical Trials Regulation
CDx, NGS and regulation: five perspectives from the Pistoia Alliance - ScienceDirect
Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today's Learning Impact Framework Efficiency? in: European Journal of Health Law Volume 27 Issue 5 (2020)
EUR-Lex - 52018SC0157 - EN - EUR-Lex
Adverse incidents of medical devices | Veracuity
EUR-Lex - 52020DC0442 - EN - EUR-Lex
Analysis of primary outpatient data for off-label use of medicines in neurology
EUR-Lex - 02009R0428-20141231 - EN - EUR-Lex
B2 – Analytical report on EU law applicable to sharing of non-personal data Support Centre for data sharing
PDF) Input analysis for two public consultations on the EU Clinical Trials Regulation
Deliverable 4.1: Gap analysis report of challenges, needs and benefits of the OOP4C analysis
Deliverable 4.1: Gap analysis report of challenges, needs and benefits of the OOP4C analysis
